ADIPOQ and chronic kidney disease: In view of the strong association between CKD and CVD, the direct correlation between adiponectin and CVD in the MDRD study may be due to a residual confounding effect of reduced renal function or processes accompanying CKD, but unadjusted for reduced GFR.